Melasma

Challenging Cases in Skin of Color Patients
August 09, 2021

In this first part of our coverage of “The Skin of Color Update Pre-Conference Virtual Symposium” held August 3, we review challenging cases of melasma, vitiligo, and post-inflammatory hyperpigmentation in skin of color patients.

Emerging Agents Augment Melasma Modalities
April 09, 2021

An array of agents for blocking visible light and lightening skin are joining the armamentarium to treat melasma. Despite this expanding number of therapeutic interventions, melasma is a chronic, therapeutically challenging disease for which there is no cure, so treatment plans should address both management of the disease and patient expectations.

Laser-assisted delivery of tranexamic acid for melasma
December 23, 2020

Findings from two recent pilot studies suggest 1927 nm fractional thulium fiber laser-assisted topical tranexamic acid delivery is a safe, effective melasma treatment option.

Targeting melasma’s vascular component improves treatment outcomes, prevent relapse
December 18, 2020

Dermatologists should consider assessing melasma patients for increased vascularity and include antivascular treatments to improve outcomes among patients whose lesions have a vascular component. 

Cysteamine cream, tranexamic acid mesotherapy reveal similar efficacy, different safety
October 14, 2020

Cysteamine cream and tranexamic acid mesotherapy demonstrated similar efficacy but yielded different safety results when being compared as a treatment for melasma, according to a recently published study.

730 nm picosecond laser safe, effective for benign pigmented lesions
October 13, 2020

Lasers typically used for tattoo removal are on the rise as a possible treatment for melasma, with the novel 730 nm picosecond laser (PicoWay, Candela) being the most recently studied device which showed to be safe and effective for treating benign pigmented lesions.

Sunscreen demonstrates strong therapeutic properties in patients with pigmentary disorders
September 02, 2020

The importance of blocking visible light in the treatment of pigmentary disorders is becoming clearer. One expert says photoprotection in patients with pigmentary conditions is a therapeutic cornerstone.

Characteristics that distinguish facial hyperpigmentation disorders
September 01, 2020

Effective treatment first requires accurate diagnosis, one expert says. He offers tips to distinguish melasma from other disorders and suggests some patients may need to be checked for diabetes and metabolic syndrome if they exhibit certain presentations.

Facial pigmentation impacts quality of life regardless of clinical severity
August 07, 2020

In a study of more than 200 men and women, clinicians scored patients’ pigmentation taking into account how much of the face was impacted and compared scores to patients’ responses to the Skindex-16 questionnaire.

Herbal cream as effective as hydroquinone for melasma
August 06, 2020

Researchers examined a group of adult women diagnosed with melasma who applied a traditional medicinal product on one side of their face and 4% hydroquinone on the other side.